SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001666965-16-000003
Filing Date
2016-02-19
Accepted
2016-02-19 13:41:37
Documents
1
Period of Report
2016-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2053
  Complete submission text file 0001666965-16-000003.txt   3710
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 820 KESWICK VA 22947
Business Address
Gilliam Richard Baxter (Reporting) CIK: 0001666965 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24477 | Film No.: 161441240